‘The Top Line’ podcast: Big Pharma’s M&A lull, the shake-up in top 10 highest paid R&D execs, plus this week’s headlinesnews2022-05-12T17:24:35+00:00May 12th, 2022|Fierce Pharma|
Pfizer partner Biovac warns of production slump amid low COVID vaccine demand: reportnews2022-05-12T16:14:33+00:00May 12th, 2022|Fierce Pharma|
Not so fast on Johnson & Johnson’s Texas Two-Step strategy as appeals court says it’ll take another looknews2022-05-12T15:37:40+00:00May 12th, 2022|Fierce Pharma|
CSL’s $11.7B Vifor buy, 2021’s biggest biopharma M&A deal, hits antitrust delaynews2022-05-12T15:34:58+00:00May 12th, 2022|Fierce Pharma|
AbbVie shows Rinvoq’s worth as maintenance therapy for Crohn’s diseasenews2022-05-12T14:01:31+00:00May 12th, 2022|Fierce Pharma|
Ready to go to FDA, can Hengrui’s China-made PD-1 liver cancer immunotherapy change the tides?news2022-05-12T13:49:59+00:00May 12th, 2022|Fierce Pharma|
Merck KGaA warns of volatile 2022 thanks to war in Ukraine and fresh COVID lockdowns in Chinanews2022-05-12T13:12:27+00:00May 12th, 2022|Fierce Pharma|
‘Dear TED’: Horizon asks patients to write letters to their eye diseasenews2022-05-12T11:30:19+00:00May 12th, 2022|Fierce Pharma|
Domestic abuse arrest of Seagen CEO came during a hazy night of booze, sex and violence: police reportnews2022-05-11T22:21:59+00:00May 11th, 2022|Fierce Pharma|
Seagen CEO’s arrest came during a hazy night of booze, sex and alleged violence: police reportnews2022-05-11T22:21:59+00:00May 11th, 2022|Fierce Pharma|
